Standard protocols for skin-focused peptide therapy typically run 3 to 4 months, with a rest period afterward
Composition Natural plant glycerin (from coconuts), almond butter (100% almonds) , Creavitalis creatine monohydrate, omega-3 ALA (from flaxseed oil), organic natural vanilla extract, natural jasmine oil, Setria L-glutathione (reduced), vitamin C (ascorbic acid), natural lemon oil, lactoferrin (from milk) , NAD+ (nicotinamide adenine dinucleotide), vitamin E Esolv (D-alpha-tocopherol), turmeric (for colour)
Possible (usually mild) side effects may include: Temporary discomfort or bruising at the injection site Mild headache or nausea in some individuals Rare irritation of the vein (phlebitis) Very rare allergic reactions (screened during pre-treatment assessment) Guided by international clinical standards (Cleveland Clinic, NHS protocols) Serious complications are uncommon when IV infusion therapy is delivered in a controlled clinical setting with appropriate patient selection and monitoring
However, it is a laboratory study, not a clinical trial on living patients
publicly stated that 14 of 19 previously Category 2 peptides including BPC-157 would return to Category 1 compounding status